PRKCB is associated with calcineurin inhibitor-induced renal dysfunction in heart transplant recipients

Pharmacogenet Genomics. 2012 May;22(5):336-43. doi: 10.1097/FPC.0b013e3283510a35.


Objectives: Single nucleotide polymorphisms (SNPs) in the transforming growth factor-β1 gene (TGFB1) have been inconsistently associated with calcineurin inhibitor (CNI)-induced renal dysfunction following cardiac transplantation. The impact of genetic variants related to the renin-angiotensin-aldosterone system (RAAS) and natriuretic peptides, which are implicated in CNI nephrotoxicity, is unknown. The primary objective of this study was to validate the association between two common variants in TGFB1 (rs1800470, rs1800471) and postcardiac transplant renal function. The secondary objective was to investigate the effect of candidate genes related to the RAAS, natriuretic peptides, and other elements involved in the intracellular signaling of these pathways.

Methods: We conducted a retrospective cohort study of 158 heart transplant recipients treated with CNIs, and evaluated the association between select SNPs and the estimated glomerular filtration rate as calculated by the Modification of Diet in Renal Disease simplified formula. A total of 273 SNPs distributed in 44 genes were tested.

Results: No association was observed between TGFB1 variants and renal function. One polymorphism in the protein kinase C-β gene (PRKCB; rs11074606), which is implicated in the RAAS intracellular signaling, was significantly associated with post-transplant estimated glomerular filtration rate after adjusting for possible confounders (P=0.00049). This marker is in linkage disequilibrium with two variants located in putative regulatory regions of the gene (rs2283541, rs1013316).

Conclusion: Our results suggest that PRKCB may be a potential predictor of CNI-induced nephrotoxicity in heart transplant recipients, and could therefore be a promising candidate to identify patients who are most susceptible to this adverse drug reaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Calcineurin / administration & dosage*
  • Calcineurin / adverse effects*
  • Calcineurin Inhibitors
  • Female
  • Genetic Association Studies
  • Glomerular Filtration Rate / genetics
  • Heart Transplantation / adverse effects*
  • Humans
  • Linkage Disequilibrium
  • Male
  • Middle Aged
  • Natriuretic Peptides / genetics
  • Polymorphism, Single Nucleotide
  • Protein Kinase C / genetics*
  • Protein Kinase C beta
  • Renal Insufficiency / etiology*
  • Renal Insufficiency / genetics
  • Renin-Angiotensin System / genetics
  • Signal Transduction
  • Transforming Growth Factor beta1 / genetics


  • Calcineurin Inhibitors
  • Natriuretic Peptides
  • TGFB1 protein, human
  • Transforming Growth Factor beta1
  • Protein Kinase C
  • Protein Kinase C beta
  • Calcineurin